The latest amendment to the US Biosafety Act removes WuXi Biologics
因醉鞭名马幌
发表于 2024-9-25 18:46:09
171
0
0
According to the official website of the US Congress on September 23 local time, there has been progress in the legislation of the US Biosafety Act, which removes WuXi Biologics from the latest amendment to the Biosafety Act. In the latest amendment, WuXi Biologics has been delisted, but WuXi AppTec, BGI Genomics, BGI Genomics, and their subsidiary Complete Genomics are still listed.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- When will the spring of domestic nine valent HPV vaccine come? Wantai Biotechnology's 100 billion dollar market value throne is difficult to secure. MSD's "disguised price reduction" hits Zhifei Biotechnology and Watson Biotechnology head-on with a
- Domestic CAR-T enterprise Legendary Biology's first quarter losses narrowed, and the company is expected to achieve profitability in 2026
